Highlights of the financial year 2019
Net sales
+3.4%
Currency-adjusted net sales growth in 2019
Net sales development
2010–2019
2010–2019
(in CHF million)
EBIT, EBITDA, Net income,
Earnings per share (EPS)
2017–2019
Earnings per share (EPS)
2017–2019
(in CHF million)(EPS: in CHF)
* Adjusted for costs in connection with the Sanitec acquisition and integration (EBITDA 2018 not adjusted)
Net income development
2010–2019
2010–2019
(in CHF million)
* Adjusted for costs in connection with the Sanitec acquisition and integration
Free cashflow
(in CHF)
644 million
+10.7% versus prior year
Operating cashflow margin
(EBITDA margin)
(EBITDA margin)
29.3%
+110 basis points versus prior year
Payout ratio
63.4%
The payout ratio is in the upper range of the 50% to 70% target corridor
Earnings per share
(in CHF)
(in CHF)
17.97
+4.4% versus prior year
R&D expenditures
(in CHF)
77 million
2.5% of net sales
Investments in property, plant and equipment and intangible assets
(in CHF)
(in CHF)
167 million
+3.1% versus prior year
Currency effects in net sales
(in CHF)
-102 million
Currency effects in EBIT
(in CHF)
(in CHF)
